Correction to “A Fluorescence Polarization Assay for Macrodomains Facilitates the Identification of Potent Inhibitors of the SARS-CoV-2 Macrodomain”
Ananya Anmangandla, Sadhan Jana, Kewen Peng, Shamar D. Wallace, Saket R. Bagde, Bryon S. Drown, Jiashu Xu, Paul J. Hergenrother, J. Christopher Fromme, Hening Lin
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2- —National Institute of General Medical Sciences10.13039/100000057
- —National Institute of Arthritis and Musculoskeletal and Skin Diseases10.13039/100000069
- —National Institute of General Medical Sciences10.13039/100000057
- —National Institute of General Medical Sciences10.13039/100000057
- —National Institute of General Medical Sciences10.13039/100000057
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAdvanced biosensing and bioanalysis techniques · Computational Drug Discovery Methods · Advanced Nanomaterials in Catalysis
We recently noticed two mistakes in the published article. In Figure 1, the structure of TAMRA was drawn incorrectly (the position of one the dimethylamino groups was wrong). In Figure 3, the structure of GS441524 contained an extra nitrogen atom. The corrected Figure 1 and Figure 3 are given below. We are sorry for this oversight and any inconvenience it may have caused. The conclusions of the article were not affected by these structure drawing errors.